Brooklyn Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Brooklyn Investment Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.79M	Buy	6,245 +2,006	+47%	+$935K	0.09%	189
2025 Q4	$1.95M	Buy	4,239 +1,462	+53%	+$630K	0.09%	186
2025 Q3	$1.23M	Sell	2,777 -70	-2%	-$29.3K	0.17%	126
2025 Q2	$1.27M	Buy	2,847 +167	+6%	+$77K	0.17%	121
2025 Q1	$1.3M	Buy	2,680 +774	+41%	+$361K	0.28%	64
2024 Q4	$768K	Buy	1,906 +33	+2%	+$15.3K	0.23%	82
2024 Q3	$871K	Buy	1,873 +87	+5%	+$41.8K	0.29%	72
2024 Q2	$751K	Hold	1,786	–	–	0.32%	72
2024 Q1	$751K	Sell	1,786 -9	-0.5%	-$3.81K	0.32%	72
2023 Q4	$730K	Buy	+1,795	New	+$663K	0.35%	67

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Brooklyn Investment Group's VRTX Position: Q1 2026 in Review

Brooklyn Investment Group increased its Vertex Pharmaceuticals (VRTX) stake by 47% in Q1 2026, buying an estimated $935K and bringing the position to 6,245 shares worth $2.79M. The position accounts for 0.09% of the portfolio, ranked #189.

Brooklyn Investment Group first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Brooklyn Investment Group held 6,245 shares of Vertex Pharmaceuticals worth $2.79M as of Q1 2026.
Brooklyn Investment Group bought 2,006 Vertex Pharmaceuticals shares in Q1 2026, an estimated $935K.
Vertex Pharmaceuticals made up 0.09% of Brooklyn Investment Group's portfolio in Q1 2026, its #189 holding.
Brooklyn Investment Group first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.